scispace - formally typeset
J

Jacques Duranteau

Researcher at University of Paris-Sud

Publications -  281
Citations -  13454

Jacques Duranteau is an academic researcher from University of Paris-Sud. The author has contributed to research in topics: Intensive care & Medicine. The author has an hindex of 52, co-authored 248 publications receiving 11130 citations. Previous affiliations of Jacques Duranteau include Paris Diderot University & University of Paris.

Papers
More filters
Journal ArticleDOI

Microcirculation in intestinal villi: a comparison between hemorrhagic and endotoxin shock.

TL;DR: It is concluded that ETX induces a significant decrease in mucosal perfusion characterized by a diminution in RBC velocity and flux in villi found even in a normotensive situation.
Journal ArticleDOI

Heterogeneous regional vascular responses to simulated transient hypovolemia in man

TL;DR: Since a sustained splanchnic vasoconstriction follows a transient normotensive hypovolemia in healthy men despite adequate treatment considering arterial pressure and cardiac output, the therapeutic goals of fluid resuscitation after Hypovolemic shock might be revisited and a supranormal value of cardiac output proposed.
Journal ArticleDOI

International study on microcirculatory shock occurrence in acutely Ill patients

TL;DR: In patients with tachycardia, the presence of an abnormal microvascular flow index was an independent, additive predictor for in-hospital mortality, and in patients withTachycardic patients, an abnormalMicrocirculatory alterations are associated with adverse outcome in subsets of critically ill patients, and an abnormal Microcirculatory Shock Occurrence in Acutely ill patients was independently associated with an increased risk of hospital death.
Journal ArticleDOI

Changes in cerebral blood flow and oxygen extraction during post-resuscitation syndrome

TL;DR: Cerebral haemodynamic and oxygenation values are altered considerably but evolve during the first 72 h following resuscitation after cardiac arrest, which may lead to a mismatch between CBF and CEO2 leading to a "luxurous perfusion" in non-survivors.